Page last updated: 2024-10-28

gyki 52466 and Glioma

gyki 52466 has been researched along with Glioma in 1 studies

GYKI 52466: an AMPA (non-NMDA) receptor antagonist; structure given in first source

Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eyüpoglu, IY1
Hahnen, E1
Heckel, A1
Siebzehnrübl, FA1
Buslei, R1
Fahlbusch, R1
Blümcke, I1

Other Studies

1 other study available for gyki 52466 and Glioma

ArticleYear
Malignant glioma-induced neuronal cell death in an organotypic glioma invasion model. Technical note.
    Journal of neurosurgery, 2005, Volume: 102, Issue:4

    Topics: Animals; Benzodiazepines; Brain Neoplasms; Cell Death; Cell Movement; Cell Proliferation; Dentate Gy

2005